Uncovering a tumor suppressor for triple-negative breast cancers

John Albeck; Joan S. Brugge

doi:10.1016/j.cell.2011.02.030

Uncovering a tumor suppressor for triple-negative breast cancers

John Albeck, Joan S. Brugge

Research output: Contribution to journal › Review article

16 Scopus citations

Abstract

"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

Original language	English (US)
Pages (from-to)	638-640
Number of pages	3
Journal	Cell
Volume	144
Issue number	5
DOIs	https://doi.org/10.1016/j.cell.2011.02.030
State	Published - Mar 4 2011
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Cite this

Albeck, J., & Brugge, J. S. (2011). Uncovering a tumor suppressor for triple-negative breast cancers. Cell, 144(5), 638-640. https://doi.org/10.1016/j.cell.2011.02.030

@article{7071d084995c4fb48032bf22dca84335,

title = "Uncovering a tumor suppressor for triple-negative breast cancers",

abstract = "{"}Triple-negative{"} breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.",

author = "John Albeck and Brugge, {Joan S.}",

year = "2011",

month = mar

day = "4",

doi = "10.1016/j.cell.2011.02.030",

language = "English (US)",

volume = "144",

pages = "638--640",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Uncovering a tumor suppressor for triple-negative breast cancers

AU - Albeck, John

AU - Brugge, Joan S.

PY - 2011/3/4

Y1 - 2011/3/4

N2 - "Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

AB - "Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

UR - http://www.scopus.com/inward/record.url?scp=79952306458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952306458&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2011.02.030

DO - 10.1016/j.cell.2011.02.030

M3 - Review article

C2 - 21376226

AN - SCOPUS:79952306458

VL - 144

SP - 638

EP - 640

JO - Cell

JF - Cell

SN - 0092-8674

IS - 5

ER -

Access to Document

10.1016/j.cell.2011.02.030